In 1985, transgenic mice bearing c-myc coupled to the Eμ enhancer were reported to consistently develop immature (pre-B) and sometimes mature B-cell lymphomas (11). The gene discussed is MYC; the disease is B-cell non-Hodgkin lymphoma.